AI assistant
PALISADE BIO, INC. — Director's Dealing 2023
Sep 14, 2023
35274_dirs_2023-09-14_22ce0f4a-8e57-4983-bb0b-b62e293a13aa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PALISADE BIO, INC. (PALI)
CIK: 0001357459
Period of Report: 2023-09-13
Reporting Person: Finley John David (Director, CEO, CFO, Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-09-13 | Common Stock, par value $0.01 | P | 15000 | $0.655 | Acquired | 28394 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, par value $0.01 | 777 | Indirect |
Footnotes
F1: Reporting Person purchased 15,000 shares of Common Stock at prices ranging from $0.636 to $0.658 with a weighted average price per share of $0.655 on September 13, 2023. The Reporting Person agrees to provide full information regarding the number of shares purchased at each separate price paid if requested by the SEC staff, the Issuer, or a security holder of the Issuer.
F2: Reporting Person is the managing member of FCW Investments LLC and has the sole investment and voting power over the securities held by this entity.